The question
Spatial transcriptomics measures which genes are active at each location in a tissue section, but it is expensive and uses up the section. H&E staining is cheap and sits on almost every clinical slide. If morphology carries enough information, a model trained on paired H&E and spatial RNA could estimate expression maps for new tissue and point to regions worth measuring. A prediction is a hypothesis about the tissue, not a new measurement, so the real question is narrower: in a patient the model has never seen, how much of the spatial RNA pattern can be read from the image, and which way of training gets closest?
The data are three colorectal cancer patients profiled with Visium HD and analyzed at 8 µm bins. A bin is a grid square, not a cell. Most measured counts are zero, and a zero can reflect sparse sampling as easily as true absence.
